Moderna Statistics
NASDAQ: MRNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
195.67-0.81 (-0.41%)
Market open · Delayed 15 min · as of Oct 8, 11:53 AM ET
Moderna by the numbers
Moderna has a market capitalization of $78.12 billion based on 399.24M shares outstanding. With trailing EPS of $-7.98, Moderna is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 48.2% above its 50-day average and 176.1% above its 200-day average.
Average daily trading volume is 17.44M shares, or about $3.41 billion in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MRNA valuation vs. peer median
| Metric | MRNA | Peer median | Difference |
|---|---|---|---|
| Market cap | $78.12B | $18.90B | +313% |
| Avg. volume | 17.44M | 1.59M | +997% |
Peer median across 8 companies: ARGX, RVMD, BIIB, BNTX, EXEL, NBIX, HALO, TECH.
Valuation
- Market cap
- $78.12B
- Price / sales (latest FY)
- 40.18
- EPS (TTM)
- $-7.98
- Shares outstanding
- 399.24M
Price and trading
- Previous close
- 196.48
- Open
- 196.43
- Day range
- 192.73 – 199.92
- 52-week range
- 22.28 – 212.22
- 52-week change
- +618.65%
- 50-day moving average
- 132.07
- Beta
- —
- Volume
- 5.13M
- Average volume
- 17.44M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 78.12B
- Forward Pe
- -43.96
- Eps
- -7.98
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 212.22
- Week52 Low
- 22.28
- Avg Volume
- 17.44M
- Shares Outstanding
- 399.24M
- Ma50
- 132.07
- Ma200
- 70.86
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -7.80%
- Pct From52w Low
- 778.23%